as declared in news-medical
URMC scientists receive award to explore new treatments for Huntington's disease
URMC scientists receive award to explore new treatments for Huntington's disease
A new award from the CHDI Foundation will advance promising research that aims to slow the progression of Huntington's disease.The funding, anticipated to total more than $10.5 million over next five years, will help University of Rochester Medical Center (URMC) scientists develop a stem cell-based therapy that swaps sick brain cells for healthy ones.The new award will go to the lab of Steve Goldman, M.D., Ph.D., the co-director of the URMC Center for Translational Neuromedicine, which has research operations in both Rochester and at the University of Copenhagen.Huntington's is a hereditary neurodegenerative disease characterized by the loss of medium spiny neurons, a nerve cell in the brain that plays a critical role in motor control.
in like manner ajc
Georgia State plans new downtown infectious disease research center
Georgia State plans new downtown infectious disease research center
Just One More Thing...We have sent you a verification email.Please check your email and click on the link to activate your AJC.com profile.If you do not receive the verification message within a few minutes of signing up, please check your Spam or Junk folder.
in addition foxnews
Long-forgotten research unearths new mystery about Lyme disease
Long-forgotten research unearths new mystery about Lyme disease
The tick hunter was hopeful he had found the cause of the disabling illness, recently named Lyme disease, that was spreading anxiety through leafy communities east of New York City.At a government lab in Montana, Willy Burgdorfer typed a letter to a colleague, reporting that blood from Lyme patients showed "very strong reactions" on a test for an obscure, tick-borne bacterium.He called it the "Swiss Agent."But further studies raised doubts about whether he had the right culprit, and 18 months later, in 1981, Burgdorfer instead pinned Lyme on another microbe.The Swiss Agent test results were forgotten.
as well news-medical
IPC PAS researchers develop new polymer that may detect early stages of kidney disease
IPC PAS researchers develop new polymer that may detect early stages of kidney disease
The advanced phase of acute kidney injury can be fatal in even one in two patients.Fortunately, now it will be possible to detect the disease in its initial stages, when treatment is still relatively simple and the prognosis good.The key to this health and life-saving manner of diagnosis is a new polymer, designed at the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw.The chemical heart of low-cost diagnostic tools capable of detecting the early stages of kidney disease may, in the near future, be a special polymer prepared by PhD student Zofia Iskierko under the supervision of Dr. Krzysztof Noworyta, in Prof. Wlodzimierz Kutner's group at the Institute of Physical Chemistry of the Polish Academy of Sciences (IPC PAS) in Warsaw.
No comments:
Post a Comment